Olema Pharmaceuticals, Inc. - Common Stock (OLMA)

56 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35,073,865 shares of 68,958,635 outstanding shares and own 51% of the company stock.
Largest 10 shareholders include BVF INC/IL (6,661,503 shares), Logos Global Management LP (3,743,875 shares), JANUS HENDERSON GROUP PLC (3,638,838 shares), Cormorant Asset Management, LP (3,195,544 shares), RA CAPITAL MANAGEMENT, L.P. (2,150,404 shares), WELLINGTON MANAGEMENT GROUP LLP (2,069,315 shares), VR Adviser, LLC (1,536,193 shares), CITADEL ADVISORS LLC (1,434,796 shares), Vivo Capital, LLC (1,238,575 shares), and Avoro Capital Advisors LLC (876,986 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.